EMERGING ROLE OF GLP-1 RECEPTOR AGONISTS IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME
Published: 2026-04-18
Abstract
Polycystic ovary syndrome(PCOS) is one of the most common endocrine disorders affecting women in reproductive age and is associated with obesity, insulin resistance, infertility and metabolic dysfunction. Recent studies have shown the potential role of GLP-1 Receptor agonist in the management of Polycystic Ovary Syndrome(PCOS).
List of references
About the Authors
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
[1]
Rashidova Asal and Shamansurova Zulaykho trans. 2026. EMERGING ROLE OF GLP-1 RECEPTOR AGONISTS IN THE MANAGEMENT OF POLYCYSTIC OVARY SYNDROME. Uzbekistan Open Conference. 11 (Apr. 2026).
